Nektar Therapeutics (NKTR) Short Interest Ratio & Short Volume $1.40 +0.03 (+1.82%) (As of 11:33 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Nektar Therapeutics Short Interest DataNektar Therapeutics (NKTR) has a short interest of 6.04 million shares, representing 3.40% of the float (the number of shares available for trading by the public). This marks a -17.37% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.9, indicating that it would take 5.9 days of the average trading volume of 1.75 million shares to cover all short positions.Current Short Interest6,040,000 sharesPrevious Short Interest7,310,000 sharesChange Vs. Previous Month-17.37%Dollar Volume Sold Short$7.79 millionShort Interest Ratio5.9 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares184,079,000 sharesFloat Size177,810,000 sharesShort Percent of Float3.40%Today's Trading Volume518,046 sharesAverage Trading Volume1,751,814 sharesToday's Volume Vs. Average30% Short Selling Nektar Therapeutics? Sign up to receive the latest short interest report for Nektar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNKTR Short Interest Over TimeNKTR Days to Cover Over TimeNKTR Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Nektar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20246,040,000 shares $7.79 million -17.4%3.4%5.9 $1.29 9/30/20247,310,000 shares $9.50 million -5.8%4.1%7.1 $1.30 9/15/20247,760,000 shares $10.17 million -5.8%4.4%5.2 $1.31 8/31/20248,240,000 shares $10.55 million -2.7%4.6%5.2 $1.28 8/15/20248,470,000 shares $10.08 million -4.1%4.8%4.9 $1.19 7/31/20248,830,000 shares $11.83 million -9.2%4.9%4.7 $1.34 Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/20249,720,000 shares $13.61 million +140.0%5.4%5 $1.40 6/30/20244,050,000 shares $5.02 million -6.7%2.3%1.7 $1.24 6/15/20244,340,000 shares $5.08 million +58.4%2.4%1.9 $1.17 5/31/20242,740,000 shares $3.48 million +3.4%1.5%1.3 $1.27 5/15/20242,650,000 shares $4.85 million -25.1%1.5%1 $1.83 4/30/20243,540,000 shares $5.17 million +13.8%2.0%1.4 $1.46 4/15/20243,110,000 shares $4.88 million +31.8%1.8%1.3 $1.57 3/31/20242,360,000 shares $2.20 million -6.0%1.3%1.2 $0.93 3/15/20242,510,000 shares $2.16 million +24.9%1.4%1.6 $0.86 2/29/20242,010,000 shares $1.43 million -18.0%1.1%1.2 $0.71 2/15/20242,450,000 shares $1.81 million -57.8%N/A2 $0.74 1/31/20245,800,000 shares $3.15 million +6.6%N/A4.8 $0.54 1/15/20245,440,000 shares $2.91 million +1.7%N/A3.7 $0.53 12/31/20235,350,000 shares $3.02 million -23.1%N/A3.4 $0.57 12/15/20236,960,000 shares $3.26 million -3.7%N/A4.5 $0.47 11/30/20237,230,000 shares $3.54 million -9.7%N/A4.6 $0.49 11/15/20238,010,000 shares $4.21 million +7.2%N/A4.7 $0.53 10/31/20237,470,000 shares $3.50 million -8.8%N/A2.8 $0.47 10/15/20238,190,000 shares $4.41 million +5.8%N/A1.4 $0.54 9/30/20237,740,000 shares $4.61 million +6.6%N/A1.3 $0.60 9/15/20237,260,000 shares $5.12 million +7.1%N/A1.2 $0.71 8/31/20236,780,000 shares $4.03 million -5.2%N/A1 $0.60 8/15/20237,150,000 shares $5.79 million +23.3%N/A1 $0.81 7/31/20235,800,000 shares $3.11 million +9.9%N/A0.9 $0.54 7/15/20235,280,000 shares $2.90 million -2.8%N/A1.5 $0.55 6/30/20235,430,000 shares $3.12 million -50.8%N/A1.4 $0.58 6/15/202311,030,000 shares $6.23 million +11.5%N/A2 $0.56 5/31/20239,890,000 shares $5.74 million -2.1%N/A2 $0.58 5/15/202310,100,000 shares $7.71 million +5.4%N/A2 $0.76 4/30/20239,580,000 shares $7.21 million +16.7%5.8%2 $0.75 4/15/20238,210,000 shares $7.60 million -3.5%N/A1.7 $0.93 3/31/20238,510,000 shares $5.98 million +20.2%N/A1.9 $0.70 3/15/20237,080,000 shares $8.07 million -19.1%N/A2.9 $1.14 2/28/20238,750,000 shares $12.08 million -11.8%N/A4.5 $1.38625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 2/15/20239,920,000 shares $30.85 million -0.1%N/A4.9 $3.11 1/31/20239,930,000 shares $27.01 million +7.7%N/A6.1 $2.72 1/15/20239,220,000 shares $23.23 million +2.4%N/A5.9 $2.52 12/30/20229,000,000 shares $20.34 million -1.6%N/A5.6 $2.26 12/15/20229,150,000 shares $24.71 million -44.4%N/A5.3 $2.70 11/30/202216,470,000 shares $46.12 million -1.9%N/A9 $2.80 11/15/202216,790,000 shares $65.82 million -3.2%N/A10.6 $3.92 10/31/202217,350,000 shares $65.24 million -0.2%N/A10.6 $3.76 10/15/202217,390,000 shares $61.73 million -0.6%N/A9.5 $3.55 9/30/202217,500,000 shares $56 million -0.5%N/A7.7 $3.20 9/15/202217,590,000 shares $64.38 million -0.2%N/A6.5 $3.66 8/31/202217,630,000 shares $69.46 million -6.5%N/A6.1 $3.94 8/15/202218,860,000 shares $92.60 million -0.7%N/A6.1 $4.91 7/31/202219,000,000 shares $75.24 million -19.4%N/A5.7 $3.96 7/15/202223,560,000 shares $84.34 million +17.1%N/A6.6 $3.58 6/30/202220,120,000 shares $76.46 million +14.1%N/A5.2 $3.80 6/15/202217,640,000 shares $59.27 million -1.2%N/A4.4 $3.36 5/31/202217,860,000 shares $62.15 million -1.3%N/A4.2 $3.48 5/15/202218,100,000 shares $72.22 million -1.3%N/A4.4 $3.99 4/30/202218,330,000 shares $75.70 million -10.3%N/A4.7 $4.13 4/15/202220,430,000 shares $125.85 million -2.3%N/A5.6 $6.16 3/31/202220,920,000 shares $112.76 million -12.1%N/A7 $5.39 3/15/202223,790,000 shares $106.58 million +11.5%N/A8.6 $4.48 2/28/202221,330,000 shares $218.42 million +3.6%N/A8.3 $10.24 2/15/202220,580,000 shares $230.08 million +4.7%11.4%8.2 $11.18 1/31/202219,660,000 shares $218.62 million +6.3%10.8%7.8 $11.12 1/15/202218,500,000 shares $223.85 million -2.5%10.2%7.6 $12.10 12/31/202118,980,000 shares $256.42 million +11.3%10.4%8.7 $13.51 12/15/202117,060,000 shares $221.10 million +5.7%9.4%8.4 $12.96 11/30/202116,140,000 shares $181.74 million -4.0%8.9%12.1 $11.26 11/15/202116,820,000 shares $224.38 million +3.2%9.2%14.9 $13.34 10/29/202116,300,000 shares $247.11 million +1.6%9.0%15.8 $15.16 10/15/202116,040,000 shares $277.65 million -0.9%8.8%18.7 $17.31 9/30/202116,190,000 shares $290.77 million -1.8%8.9%18.9 $17.96 9/15/202116,480,000 shares $266.65 million -5.0%9.1%19 $16.18 8/31/202117,350,000 shares $268.58 million -1.5%9.6%20.4 $15.48 8/13/202117,620,000 shares $251.79 million -2.0%9.7%20.9 $14.29 7/30/202117,970,000 shares $283.75 million +0.7%10.0%21 $15.79 7/15/202117,840,000 shares $295.97 million -1.8%9.9%19.8 $16.59 6/30/202118,160,000 shares $311.63 million -0.8%10.1%20 $17.16 6/15/202118,310,000 shares $325.00 million +1.5%10.2%20.8 $17.75 5/28/202118,040,000 shares $325.98 million -0.4%10.0%20.7 $18.07 5/14/202118,110,000 shares $341.55 million -5.9%N/A19.9 $18.86 4/30/202119,240,000 shares $386.53 million -2.2%N/A18.2 $20.09 4/15/202119,680,000 shares $376.68 million +2.1%N/A16 $19.14 3/31/202119,280,000 shares $376.15 million -3.3%N/A15.3 $19.51 3/15/202119,940,000 shares $455.03 million -6.2%N/A14.9 $22.82 2/26/202121,250,000 shares $476.85 million +0.4%N/A15.9 $22.44 2/12/202121,160,000 shares $481.39 million -7.6%N/A16.7 $22.75 1/29/202122,900,000 shares $422.28 million -4.5%N/A19.4 $18.44625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here 1/15/202123,970,000 shares $426.67 million -1.0%N/A22.6 $17.80 12/31/202024,200,000 shares $434.15 million -1.5%N/A24 $17.94 12/15/202024,560,000 shares $433.24 million -0.3%N/A23.8 $17.64 11/30/202024,640,000 shares $413.71 million -0.2%N/A23.7 $16.79 11/15/202024,700,000 shares $426.57 million -2.1%N/A22.9 $17.27 10/30/202025,240,000 shares $409.14 million -2.5%N/A23.8 $16.21 10/15/202025,890,000 shares $454.11 million +1.7%N/A26.4 $17.54 9/30/202025,470,000 shares $422.55 million -1.3%N/A27.5 $16.59 9/15/202025,800,000 shares $516.26 million -1.7%N/A28.3 $20.01 8/31/202026,240,000 shares $507.48 million -0.7%N/A29 $19.34 8/14/202026,420,000 shares $516.51 million -1.3%N/A27.5 $19.55 7/31/202026,770,000 shares $593.22 million +0.1%N/A26 $22.16 7/15/202026,740,000 shares $630.80 million -2.3%N/A24.5 $23.59 6/30/202027,360,000 shares $613.41 million -1.2%N/A23 $22.42 6/15/202027,700,000 shares $567.57 million +3.3%N/A22.3 $20.49 5/29/202026,810,000 shares $595.45 million -3.3%N/A19.4 $22.21 5/15/202027,730,000 shares $610.61 million -1.3%N/A19 $22.02 4/30/202028,090,000 shares $539.33 million -0.9%N/A18.6 $19.20 4/15/202028,340,000 shares $521.46 million +2.5%N/A18.1 $18.40 3/31/202027,640,000 shares $541.74 million +0.8%N/A13 $19.60 3/13/202027,428,900 shares $515.11 million +1.3%N/A17.3 $18.78 2/28/202027,070,000 shares $435.01 million -2.3%N/A12.4 $16.07 2/14/202027,700,000 shares $498.05 million -3.5%16.0%11.7 $17.98 1/31/202028,690,000 shares $614.25 million -3.0%16.6%10.7 $21.41 1/15/202029,590,000 shares $662.82 million +0.7%17.1%10.7 $22.40 12/31/201929,390,000 shares $621.01 million -4.9%17.0%10.9 $21.13 NKTR Short Interest - Frequently Asked Questions What is Nektar Therapeutics' current short interest? Short interest is the volume of Nektar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 6,040,000 shares of NKTR short. 3.40% of Nektar Therapeutics' shares are currently sold short. Learn More on Nektar Therapeutics' current short interest. What is a good short interest ratio for Nektar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKTR shares currently have a short interest ratio of 6.0. Learn More on Nektar Therapeutics's short interest ratio. What is a good short interest percentage for Nektar Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.40% of Nektar Therapeutics' floating shares are currently sold short. Is Nektar Therapeutics' short interest increasing or decreasing? Nektar Therapeutics saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 6,040,000 shares, a decrease of 17.4% from the previous total of 7,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Nektar Therapeutics' float size? Nektar Therapeutics currently has issued a total of 184,079,000 shares. Some of Nektar Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nektar Therapeutics currently has a public float of 177,810,000 shares. How does Nektar Therapeutics' short interest compare to its competitors? 3.40% of Nektar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nektar Therapeutics: Atea Pharmaceuticals, Inc. (3.55%), ADC Therapeutics SA (3.63%), Seres Therapeutics, Inc. (10.61%), Pacira BioSciences, Inc. (13.31%), Omeros Co. (21.89%), Assembly Biosciences, Inc. (0.37%), Cumberland Pharmaceuticals Inc. (0.51%), Agios Pharmaceuticals, Inc. (7.45%), Alkermes plc (9.78%), Novo Nordisk A/S (0.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Nektar Therapeutics stock? Short selling NKTR is an investing strategy that aims to generate trading profit from Nektar Therapeutics as its price is falling. NKTR shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nektar Therapeutics? A short squeeze for Nektar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NKTR, which in turn drives the price of the stock up even further. How often is Nektar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKTR, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies AVIR Short Interest ADCT Short Interest MCRB Short Interest PCRX Short Interest OMER Short Interest ASMB Short Interest CPIX Short Interest AGIO Short Interest ALKS Short Interest NVO Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NKTR) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredUrgent: This election is riggedI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
